SecBot SecBot
144 ·Filed May 13, 2026

INSM

INSMED Inc
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001628280-26-034690
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale by an officer with no material impact on the stock. Monitor for any acceleration of insider selling or a pattern of larger dispositions ahead of upcoming earnings or catalysts, but no immediate action is warranted.

DirectionNeutral
Confidencemedium
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$115.62
T+0 close · May 13, 2026 · via day close
Latest settled
+16.55%
T+60 · $134.75
Vs SPY
+12.96%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 14 $115.62entry
  2. T+1 · 6mo ago −5.60%α −4.38% · $109.14
  3. T+5 · 6mo ago −5.27%α −4.55% · $109.53
  4. T+20 · 5mo ago −15.37%α −14.51% · $97.85
  5. T+60 · 3mo ago +16.55%α +12.96% · $134.75

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Sara Bonstein, an officer of Insmed, filed a Form 144 on May 13, 2026, indicating intent to sell 8,272 shares of common stock through Merrill Lynch. At the current market cap of $25.1B, the proposed sale value of approximately $2.2M is modest relative to the company's size and represents a routine insider transaction. The filing does not disclose the specific role of the officer, but the sale is not flagged as a CEO/CFO disposition and follows a pattern of recent insider selling activity.

Key Facts

  • Insider Sara Bonstein (officer) filed Form 144 to sell 8,272 shares of INSM common stock.
  • Sale is planned through Merrill Lynch with an estimated market value of approximately $2.2M based on current price.
  • Transaction date noted as May 11, 2026, with filing on May 13, 2026.
  • Recent 30-day insider activity includes 3 sells totaling $1.6M, consistent with routine insider selling.
  • No CEO or CFO sale indicated; the filing is a standard intent-to-sell notice.

Financial Impact

Proposed sale of 8,272 shares valued at approximately $2.2M, representing a small fraction of total insider holdings and less than 0.01% of market cap.

dilutioninsider holdings

Risk Factors

  • Potential for additional insider selling if the officer or other insiders increase dispositions.
  • No material risk to the company's fundamentals from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
96% bullish (28 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-034690
Document: 0001628280-26-034690-index.html0001628280-26-034690
Document: 0001628280-26-034690.txt0001628280-26-034690

Track record

24 reports on INSM

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +31.86% at T+60 after the Mar 30, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 3, 202613d ago 144 Neutral 2/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
  2. Nov 3, 202613d ago 3 Neutral 1/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
  3. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $111.59 Now $122.88 +10.12% settles Nov 27
  4. Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $94.04 Now $122.88 +30.67% settles Nov 18
  5. Oct 20, 202627d ago 8-K Neutral 3/10 Entry $95.67 Now $122.88 +28.44% settles Nov 17
  6. Oct 5, 20266w ago 8-K Neutral 4/10 Entry $103.83 to $112.58 Now $122.88 +18.35% ▲ +8.43% +10.89% vs SPY
  7. Aug 19, 202612w ago Insider Cluster Neutral 4/10 Entry $125.08 to $120.00 Now $122.88 −1.76% ▼ −4.06% −4.19% vs SPY
  8. Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $126.33 to $129.41 Now $122.88 −2.73% ▲ +2.44% +4.19% vs SPY
  9. Aug 6, 202614w ago 8-K Bullish 8/10 Entry $132.55 to $126.68 Now $122.88 −7.30% ▼ −4.43% −5.03% vs SPY
  10. Jul 24, 202616w ago Institutional Cluster Neutral 4/10 Entry $106.92 to $125.77 Now $122.88 +14.93% ▲ +17.63% +14.00% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens Wed (11h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 13, 2026